Multiple labeling of a potent CX3CR1 antagonist for the treatment of multiple sclerosis-Reference-Cited by-同舟云学术

Multiple labeling of a potent CX3CR1 antagonist for the treatment of multiple sclerosis

Author:

Malmquist Jonas¹,Ström Peter¹

Affiliation:

1. Isotope Chemistry, Screening and Profiling Global DMPK IM AstraZeneca; Research Development | Innovative Medicines; SE-151 85; Södertälje; Sweden

Publisher

Wiley

Subject

Organic Chemistry,Spectroscopy,Drug Discovery,Radiology, Nuclear Medicine and imaging,Biochemistry,Analytical Chemistry

Link

Reference16 articles.

1. R. Johansson S. Karlström A. Kers G. Nordvall T. Rein C. Slivo PCT Int. Appl . WO 2008039139 A1 2008

2. R. Johansson S. Karlström A. Kers G. Nordvall T. Rein C. Slivo PCT Int. Appl . WO 2008039138 A1 2008

3. G. Nordvall C. Ray T. Rein D. Sohn PCT Int. Appl . WO 2006107257 A1 2006

4. G. Nordvall C. Ray T. Rein D. Sohn PCT Int. Appl . WO 2006107258 A1 2006

5. G. Nordvall T. Rein D. Sohn R. Zemribo PCT Int. Appl . WO 2005033115 A1 2005

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

3. Imaging agent of a TRPA1 inhibitor;Journal of Labelled Compounds and Radiopharmaceuticals;2013-02-16